Company Pacific Biosciences of California, Inc. Börse Stuttgart
Equities
P09
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 EUR | +0.78% |
|
-8.16% | -86.31% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Instrument
60.1
%
| 49 | 38.0 % | 120 | 60.1 % | +147.24% |
Consumable
31.6
%
| 60 | 46.7 % | 63 | 31.6 % | +5.74% |
Service and Other
8.3
%
| 20 | 15.3 % | 17 | 8.3 % | -15.08% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
52.6
%
| 70 | 54.2 % | 105 | 52.6 % | +51.54% |
Asia-Pacific
27.2
%
| 36 | 28.2 % | 54 | 27.2 % | +50.65% |
Europe, Middle East, and Africa
20.3
%
| 23 | 17.6 % | 41 | 20.3 % | +79.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Mark van Oene
COO | Chief Operating Officer | 51 | 21-01-07 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 14-12-16 |
Todd Friedman
IRC | Investor Relations Contact | - | - |
Mike Goloubef
PRN | Corporate Officer/Principal | - | 19-12-31 |
Natalie Welch
HRO | Human Resources Officer | - | 08-09-30 |
Neil Ward
PRN | Corporate Officer/Principal | - | 21-06-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Director/Board Member | 70 | 08-12-31 | |
Lucy Shapiro
BRD | Director/Board Member | 83 | 12-09-11 |
Bill Ericson
BRD | Director/Board Member | 65 | 03-12-31 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 14-12-16 |
David Meline
BRD | Director/Board Member | 66 | 23-10-12 |
Hannah Valantine
BRD | Director/Board Member | 72 | 21-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 272,355,892 | 267,170,934 ( 98.10 %) | 0 | 98.10 % |
Company contact information
Pacific Biosciences of California, Inc.
1305 O'Brien Drive
94025, Menlo Park
+650 521 8000
http://www.pacb.com![address Pacific Biosciences of California, Inc.(P09)](https://cdn.zonebourse.com/static/address/50917222.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+2.66% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B |
- Stock Market
- Equities
- PACB Stock
- P09 Stock
- Company Pacific Biosciences of California, Inc.